“…Furthermore, due to a high prevalence rate of drug resistance, universal drug susceptibility testing of M. tuberculosis is strongly recommended by the World Health Organization. [1] It is estimated that 3.3% of new TB cases are multidrug-resistant TB (MDR-TB), and of these, 9.7% of patients have extensively drug-resistant TB defined as MDR-TB plus resistance to at least one fluoroquinolone and a second-line injectable medication. [2] Therefore, drug susceptibility of M. tuberculosis should be considered when choosing treatment regimen.…”